| Literature DB >> 27228329 |
Pimlapas Leekitcharoenphon1, Ibrahim Raufu2, Mette T Nielsen1, Birthe S Rosenqvist Lund3, James A Ameh4, Abdul G Ambali2, Gitte Sørensen3, Simon Le Hello5, Frank M Aarestrup1, Rene S Hendriksen1.
Abstract
Twenty-six Salmonella enterica serovar Eko isolated from various sources in Nigeria were investigated by whole genome sequencing to identify the source of human infections. Diversity among the isolates was observed and camel and cattle were identified as the primary reservoirs and the most likely source of the human infections.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27228329 PMCID: PMC4881965 DOI: 10.1371/journal.pone.0156212
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Phylogenetic reconstruction of the genetic relationships among the S. Eko isolates from cattle, camel, humans and fish in the north-eastern region of Nigeria.
MIC determination and antimicrobial resistance genes of S. Eko isolates from different sources in the north-eastern region of Nigeria.
| Sample no. | Origin | Resistance breakpoints (μg/ml) and percent similarity of resistance genes | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP R>8 | STR R>16 | SMX R>256 | TET R>8 | TMP R>2 | |||||||
| 2/3 | Cattle/lymph nodes | 2 | - | 16 | - | 512 | - | < = 2 | - | < = 1 | - |
| 40/3 | Cattle/lymph nodes | 2 | - | 16 | - | 256 | - | < = 2 | - | < = 1 | - |
| 47/3 | Cattle/lymph nodes | 2 | - | 16 | - | 256 | - | 4 | - | 2 | - |
| 48/3 | Cattle/lymph nodes | 2 | - | 16 | - | < = 64 | - | < = 2 | - | < = 1 | - |
| 53/3 | Cattle/lymph nodes | 2 | - | 16 | - | < = 64 | - | < = 2 | - | < = 1 | - |
| 62/3 | Cattle/lymph nodes | < = 1 | - | 16 | - | < = 64 | - | < = 2 | - | < = 1 | - |
| 31/3 | Cattle/ intestine | 2 | - | 32 | - | 256 | - | < = 2 | - | < = 1 | - |
| 88/3 | Cattle/ intestine | 2 | - | 16 | - | 128 | - | < = 2 | - | < = 1 | - |
| 93/3 | Cattle/ intestine | 2 | - | < = 8 | - | < = 64 | - | < = 2 | - | < = 1 | - |
| 82/3 | Cattle/liver | 2 | - | 16 | - | 256 | - | < = 2 | - | < = 1 | - |
| 85/3 | Cattle/liver | < = 1 | - | < = 8 | - | 512 | - | < = 2 | - | < = 1 | - |
| 19/3 | Camel/ intestine | 2 | - | 16 | - | 256 | - | < = 2 | - | < = 1 | - |
| 60/3 | Camel/ intestine | < = 1 | - | 16 | - | < = 64 | - | < = 2 | - | < = 1 | - |
| 96/3 | Camel/ intestine | 2 | - | < = 8 | - | 128 | - | < = 2 | - | < = 1 | - |
| 43/3 | Camel/feces | 2 | - | 16 | - | 512 | - | < = 2 | - | < = 1 | - |
| 39/3 | Camel/spleen | 2 | - | 16 | - | 256 | - | < = 2 | - | < = 1 | - |
| 64/3 | Camel/spleen | 2 | - | < = 8 | - | 128 | - | < = 2 | - | < = 1 | - |
| 94/3 | Camel/spleen | < = 1 | - | < = 8 | - | 256 | - | < = 2 | - | < = 1 | - |
| 9 | Fish/intestine | >32 | + | 16 | + | >1024 | + | >32 | + | > = 32 | + |
| 10 | Human/feces | >32 | + | 16 | + | >1024 | + | >32 | + | > = 32 | + |
| 29 | Human/feces | >32 | + | 16 | + | >1024 | + | >32 | + | > = 32 | + |
| 44/3 | Human/feces | 4 | - | 32 | - | 256 | - | < = 2 | - | < = 1 | - |
| 90 | Human/feces | >32 | + | 16 | + | >1024 | + | >32 | + | > = 32 | + |
| 91 | Human/feces | >32 | + | 16 | + | >1024 | + | >32 | + | > = 32 | + |
| 92 | Human/feces | > = 32 | + | 16 | + | > = 1024 | + | > = 32 | + | > = 32 | + |
MIC (μg/mL) determined in accordance with CLSI standards. Abbreviations: +, presences of the resistance gene; AMP, ampicillin; STR, streptomycin; SMX, sulfamethoxazole; TET, tetracyclin; TMP, trimethoprim. The isolates were susceptible to the following antimicrobial agents: AMC, amoxicillin-clavulanic acid; APR, apramycin; CHL, chloramphenicol; CIP, ciprofloxacin; COL, colistin; CTX, cefotaxime; FFN, florfenicol; GEN, gentamicin; NAL, nalidixic acid; NEO, neomycin; SPT, spectinomycin; XNL, ceftiofur.